QTREX Quantum Ltd.

We are a specialty medical device company focused on the research, development, manufacturing, and commercialization of proprietary life support technologies. Our technology aims to supersede and revolutionize the global mechanical ventilation market. An estimated up to 20 million patients each year in ICUs are treated with invasive mechanical ventilation. Mortality rates among patients undergoing prolonged mechanical ventilation may exceed 50%. Mechanical ventilators are typically used when patients are unable to breathe adequately on their own due to acute respiratory failure and require assisted breathing. During mechanical ventilation, patients are generally placed under heavy sedation or medically induced coma, and a tube is inserted into the airway. The ventilator then delivers oxygen-rich air into the lungs to facilitate the transfer of oxygen into the bloodstream and vital organs. Patients can often experience complications associated with mechanical ventilators, such as increased risk, costs of care, extended lengths of stay, frequent incidence of infections, ventilator dependence, and high mortality rates. These complications may include bacterial infections, lung damage, collapsed lung, and changes in heart and blood flow. Prolonged ventilation may involve replacing the mouth tube with one inserted through an incision in the neck. In cases where recovery is unlikely, mechanical ventilation may prolong the dying process, causing unnecessary suffering. Our INSPIRA ART novel technology could potentially assist ICU patients placed on mechanical ventilators.